ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,438Medicare Part D Prescriptions Filled, Including Refills

Rank: 103 out of 1448

$785K Total Retail Price of All Prescriptions

Rank: 55 out of 1448

708 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 7,949 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

49% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$93 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METOPROLOL TARTRATE 542 512 1 9
CARVEDILOL 541 505 2 1
PLAVIX 470 444 3 14
DIOVAN 445 408 4 15
WELCHOL 442 388 10 5 103
CLOPIDOGREL 437 408 6 10
AMLODIPINE BESYLATE 348 337 7 2
ISOSORBIDE MONONITRATE ER 276 262 8 16
FAMOTIDINE 253 231 9 60
DIGOXIN 242 236 10 13
BENICAR 216 214 11 50
LOVAZA 205 200 12 39
AVODART 189 189 13 120
ATORVASTATIN CALCIUM 185 177 14 4
ATENOLOL 180 179 15 12
SIMVASTATIN 160 139 16 3
ZETIA 152 130 17 28
AZITHROMYCIN 142 135 18 76
HYDRALAZINE HCL 132 128 19 44
LOSARTAN POTASSIUM 115 109 20 11
EXFORGE 113 109 21 80
LIDODERM 101 101 22 81
NIFEDIPINE ER 81 79 23 59
AMOXICILLIN 67 65 24 142
COUMADIN 67 67 24 101
LIPITOR 64 58 26 30
RANEXA 64 39 26 37
FUROSEMIDE 63 59 28 7
PANTOPRAZOLE SODIUM 62 61 29 42
METOPROLOL SUCCINATE 62 58 29 6
LISINOPRIL 60 49 31 5
TRILIPIX 60 60 31 86
BYSTOLIC 59 59 33 32
LOVASTATIN 58 53 34 35
COREG CR 58 58 34 83
NITROSTAT 53 40 36 31
CRESTOR 51 48 37 17
MULTAQ 51 50 37 57
WARFARIN SODIUM 51 51 37 8
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.